Treatment of menorrhagia with intrauterine release of progesterone

A Bergqvist, Agneta Bergqvist, G Rybo
British journal of obstetrics and gynaecology · 1983 · vol. 90(3) , pp. 255–258 · doi:10.1111/j.1471-0528.1983.tb08620.x · PMID:6830732 · W2066275703
Other OA: closed CC0 ⤵ 20 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study inserted a progesterone-releasing device into 12 women with menorrhagia, finding a significant reduction in menstrual blood loss by 35% after 12 months.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In 12 women with menorrhagia (greater than or equal to 80 ml per menstrual period) a progesterone-releasing device (Progestasert) was inserted. The women were followed by repeated measurements of the blood loss for 12 periods. The menstrual blood loss was significantly reduced after 1 month but the duration of bleeding was somewhat prolonged. Twelve months after insertion the menstrual blood loss amounted to 35% of the blood loss before the insertion. The Progestasert is a valuable treatment for menorrhagia.

My notes (saved in your browser only)

MeSH descriptors

Menorrhagia Progesterone Adult Female Humans Intrauterine Devices, Medicated Iron Iron Menorrhagia Menorrhagia Menorrhagia Menstruation Middle Aged Progesterone Progesterone

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (23)

Cited by (20)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:58:26.348914+00:00
License: CC0 · commercial use OK